|

Science Resources RSS Feeds
|
 |
 |
 |
Researchers develop new ultrasensitive assay to detect most poisonous substance known
May 01, 2008
City of Hope and California Department of Public Health collaborate on discovery DUARTE, Calif. -- Scientists at City of Hope and the California Department of Public Health have developed a new ultrasensitive assay to detect botulinum neurotoxin. The toxin is one of the most poisonous substances known that can cause life-threatening disease, and is considered a major potential bioterrorism threat agent. The research team's work is published today in the online journal PLoS ONE ( http://www.plosone.org/doi/pone.0002041).
Botulinum neurotoxin is produced by the bacterium Clostridium botulinum. When ingested, the toxin disables nerve function and can result in paralysis and even death. Botulism normally results when a person eats food tainted with C. botulinum bacteria or if a wound is infected by the bacterium. Infants, whose digestive systems are not yet fully developed, also are susceptible to the disease if the bacterium gains a foothold in their intestinal tract. The Centers for Disease Control and Prevention identify botulinum neurotoxin as one of six "maximum threat" bioterrorism agents due to its potency, lethality and ease of production and transport. One gram of botulinum toxin could kill more than 1 million people, according to a 2001 study in the Journal of the American Medical Association.
"The new test is at least ten thousand times more sensitive and produces results much faster than the current detection method for botulinum neurotoxin," said Markus Kalkum, Ph.D., assistant professor, Division of Immunology, City of Hope, and lead researcher in the study. "Wide use of the new assay would improve food safety and food processing technology, speed up and improve the diagnosis and treatment of human disease, advance the development of novel therapeutics, and greatly enhance the country's ability to detect and defend against a bioterrorism attack."
The collaborative research team developed a test that is less expensive, faster and easier to perform than current testing options. They achieved this through the use of microscopic beads and special photochemicals that glow under ultraviolet light to achieve a heightened level of sensitivity. The microscopic beads are coated with antibodies to the botulinum neurotoxin and then mixed with the liquefied sample to be tested. The antibodies latch on to any botulinum neurotoxin molecules present in the solution and are then used to convert a special chemical into a fluorescent dye that glows in the dark when illuminated with blue or ultraviolet light. The new assay works well in liquid foods such as milk and carrot juice, and in blood serum.
The testing method has possible application in diagnosing other diseases. Researchers are investigating the potential use of antibodies for different diseases to expand the scope of the test.
Public Library of Science
|
 |
 |
 |
 |
 |
Related Botulinum Neurotoxin Current Events and Botulinum Neurotoxin News Articles Botulinum Neurotoxin Current Events and Botulinum Neurotoxin News RSS Dysport proves safe, effective anti-wrinkle treatment, UT Southwestern plastic surgeons find The new anti-wrinkle facial filler Dysport, which could be used as an alternative to Botox, noticeably reduced frown lines between the eyes, according to users and independent reviewers in a study involving plastic surgeons at UT Southwestern Medical Center.
Nose-spray vaccine against botulism effective in first tests A preclinical study found a new nasal spray vaccine to provide complete protection against a major botulism toxin, according to a study published today in the Nature journal Gene Therapy.
Scientists Reveal Structure of New Botulism Nerve Toxin Subtype cientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have determined the atomic-level structure of a third subtype of botulinum neurotoxin - a deadly toxin produced by certain bacteria that causes the disease botulism, and is also used in cosmetic and therapeutic applications such as reducing wrinkles and calming a hyperactive bladder.
Scientists Determine Drug Target for the Most Potent Botulinum Neurotoxin Botulinum neurotoxin -- responsible for the deadly food poisoning disease botulism and for the beneficial effects of smoothing out facial wrinkles - can also be used as a dreaded biological weapon.
Scripps research scientists: Compounds show significant promise against potential bioweapon toxins Because of the high cost and limited applicability of currently available treatments, the newly identified compounds have the potential to fill the existing therapy gap and to provide protection against a bioterrorism attack using the toxin.
Study helps explain why botulinum toxin is so deadly A pilot without a map can locate an airport by first finding a nearby landmark, like a big river, and then searching for the airport.
Botulism study could lead to new vaccines and treatments to counter bioterrorist attacks Of all the weapons in the bioterrorist arsenal, none is as potent as botulinum neurotoxin, which causes botulism-a potentially fatal disease with symptoms that include severe paralysis of the limbs and respiratory muscles.
Molecular structure reveals how botulinum toxin attaches to nerve cells Botulism is a life-threatening disease caused by exposure to botulinum neurotoxins, which are among the most potent toxins known. These neurotoxins are produced by Clostridium botulinum, a bacterium found in soil and food.
Seeing a neurotoxin's deadly grip Two Howard Hughes Medical Institute research teams working independently have discovered new information about how the botulinum neurotoxin shuts down neurons with deadly efficiency.
New wrinkle in Botox treatment could lead to lower doses, better safety There may soon be a better way to fight unsightly wrinkles. Researchers have discovered a novel way to increase the potency of botulinum neurotoxin treatments - commonly known as Botox - that they say could one day allow patients to receive the injections less frequently while maintaining or even enhancing its cosmetic benefits. More Botulinum Neurotoxin Current Events and Botulinum Neurotoxin News Articles
|
 |
 |
 |
|
|
A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment ... from: Journal of Drugs in Dermatology
by Alastair Carruthers (Author), Jean Carruthers (Author)
This digital document is an article from Journal of Drugs in Dermatology, published by Journal of Drugs in Dermatology, Inc. on October 1, 2009. The length of the article is 4550 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes.(ORIGINAL ARATICLES)(Report) Author: Alastair Carruthers Publication: Journal of Drugs in Dermatology (Magazine/Journal) Date: October 1, 2009 Publisher: Journal of Drugs in Dermatology, Inc. Volume: 8 Issue: 10 ...
|
![Enzyme-amplified protein microarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant ... [An article from: Analytica Chimica Acta]](http://ecx.images-amazon.com/images/I/415FBN4EPVL._SL160_.jpg)
|
Enzyme-amplified protein microarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant ... [An article from: Analytica Chimica Acta]
by S.M. Varnum (Author), M.G. Warner (Author), B. Dockendorff (Author), Anheier (Author)
This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: Two immunoassay platforms were developed for either the sensitive or rapid detection of botulinum neurotoxin A (BoNT/A), using high-affinity recombinant monoclonal antibodies against the receptor binding domain of the heavy chain of BoNT/A. These antibodies also bind the same epitopes of the receptor binding domain present on a nontoxic recombinant heavy chain fragment used for assay development and testing in the current study. An enzyme-linked immunosorbent assay (ELISA) microarray using tyramide...
|
|
|
Botulinum neurotoxin detection and differentiation by mass spectrometry.: An article from: Emerging Infectious Diseases
by John R. Barr (Author), Hercules Moura (Author), Anne E. Boyer (Author), Adrian R. Woolfitt (Author), Suzanne R. Kalb (Author), Antonis Pavlopoulos (Author), Lisa G. McWilliams (Author), Jurgen G. Schmidt (Author), Rodolfo A. Martinez (Author), David L. Ashley (Author)
This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on October 1, 2005. The length of the article is 4407 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Botulinum neurotoxin detection and differentiation by mass spectrometry. Author: John R. Barr Publication: Emerging Infectious Diseases (Magazine/Journal) Date: October 1, 2005 Publisher: Thomson Gale Volume: 11 Issue: 10 Page: 1578(6)
Distributed by Thomson...
|
|
|
Botulinum Neurotoxin and Tetanus Toxin
by Lance L. Simpson (Editor)
|
![Plastic enzyme-linked immunosorbent assays (ELISA)-on-a-chip biosensor for botulinum neurotoxin A [An article from: Analytica Chimica Acta]](http://ecx.images-amazon.com/images/I/415FBN4EPVL._SL160_.jpg)
|
Plastic enzyme-linked immunosorbent assays (ELISA)-on-a-chip biosensor for botulinum neurotoxin A [An article from: Analytica Chimica Acta]
by S.M. Han (Author), J.H. Cho (Author), I.H. Cho (Author), E.H. Paek (Author), H.B. Oh (Author)
This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: A plastic ELISA-on-a-chip (EOC) employing the concept of cross-flow immuno-chromatographic analysis was applied to the measurement of botulinum neurotoxin A (BoNT/A) as agent for bio-terrorism. Two monoclonal antibodies specific to the heavy chain of the toxin were raised and identified to form sandwich binding complexes as the pair with the analyte. For the construction of an immuno-strip, one was utilized as the capture antibody immobilized onto nitrocellulose membrane and the other as the detection coupled...
|

|
Botulinum and Tetanus Neurotoxins
by B.R. DasGupta (Editor)
|

|
Prevention and Management of Headache - New Insights Into the Role for Botulinum Neurotoxins, Selected Abstracts Reviewed By an Expert Panel (Review of Recent Scientific Presentations on Headache)
by Julio Pascual, Stanley Golanty Reviewing Panel: Stepephen Silberstein (Author)
|
|
|
An Educational DVD Series on Botulinum Neurotoxin Therapy (Virtual Visiting Professor)
by NTI (Author), Bruce Rector (Editor)
Modules:
1. Basic Science of Botulinum Neurotoxins
2. Improving the Management of Muscle Overactivity in the Upper Motor Neuron Syndrome with Focal Chemodenervation.
3. Muscle Overactivity in the Upper Motor Neuron Syndrome: Functional and Anatomical Considerations.
4. Potential Therapeutic Application of Botulinum Toxin in Overactive Bladder: Clinical, Scientific and Technical Aspects.
5. M.E.N.T.O.R.S. Focus on Muscular Pain
6. M.E.N.T.O.R.S. Focus on Cerebral Palsy
|
|
|
Botulinum and Tetanus Neurotoxins
by Editor-B.R. DasGupta (Author)
|

|
Treatments from Toxins: The Therapeutic Potential of Clostridial Neurotoxins
by Keith Alan Foster (Editor), Peter Hambleton (Editor), Clifford C. Shone (Editor)
As little as two decades ago, deliberately injecting botulinum toxin into patients would have seemed foolhardy at best and criminal at worst. The increased clinical use of botulinum toxins has expanded the body of knowledge available on the structure and function of these proteins. This knowledge can be applied to topics as varied as therapies based on the endopeptidase activity of the toxins, vaccine development, protection against botulism, and vectors for neuronal drug delivery. Based on recent scientific and clinical information from top international authorities, Treatments from Toxins: The Therapeutic Potential of Clostridial Neurotoxins reviews the status of current research and development and identifies significant developments.
Drawing on their vast experience in this...
|
|
 |
|